Infocus Therapeutics

InFocus Therapeutics is an AI-driven drug discovery company pioneering best-in-class RNA-targeting molecular glues to unlock new chemical space for transcriptional modulation and address diseases with high unmet need. Powered by a scalable, tech-enabled discovery engine, we are advancing a diversified pipeline across oncology and neuromuscular indications, with multiple programs progressing toward preclinical proof-of-concept. With a world-class founding team, strong IP, and multi-billion-dollar market potential across indications, InFocus is positioned to deliver transformative patient outcomes and sustainable value creation.